Prothena Corporation plc (PRTA)
US$ 10.48-3.32%
Price Chart
Key Statistics
Market Cap
$ 519.43M
P/E Ratio
0.00
Revenue (TTM)
$ 135.16M
Volume
740.78K
52W High
$ 25.42
52W Low
$ 9.00
Dividend Yield
0.00%
Beta
0.07
Technicals
50-Day MA
12.6872
200-Day MA
16.4766
52 Week High
25.42
52 Week Low
9
About PRTA
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States. I.
Employees
163
Headquarters
Dublin, Ireland
CEO
Dr. Gene G. Kinney Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg